CelGro® completes pivotal step in TGA approval process
● Orthocell successfully completes the Australian TGA Conformity Assessment process and
initiates market authorisation
● Market authorisation expected Q1 CY2021 enabling the supply of CelGro® in dental bone and
tissue regeneration procedures
● Australian reimbursement application in progress
● Orthocell is well positioned to gain US FDA approval in CY2021
Ann: CelGro Completes Pivotal Step in TGA Approval Process, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.5¢ |
Change
-0.040(5.84%) |
Mkt cap ! $135.8M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 64.0¢ | $608.4K | 935.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11562 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 3800 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |